Restenosis
Information
- Disease name
- Restenosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00493597 | Completed | Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis | October 2007 | October 26, 2020 | |
NCT00647504 | Completed | Prospective Clinical Observational Registry Including Consecutive Patients With In-stent Restenosis or Stent Thrombosis | October 2007 | March 2011 | |
NCT01405248 | Completed | Phase 3 | Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting | July 2011 | January 2014 |
NCT01466634 | Completed | Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis | August 2011 | October 2011 | |
NCT01632371 | Completed | Phase 4 | Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4 | June 2012 | November 2016 |
NCT01722877 | Completed | N/A | JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions | October 2012 | September 2015 |
NCT01735825 | Completed | N/A | Treatment of Coronary In-Stent Restenosis | January 2012 | June 2018 |
NCT01861860 | Completed | N/A | OPtimized Stenting Using Intravascular Ultrasound(IVUS) in Long lEsion: Rationale for Simplified criteriA | October 2012 | July 2018 |
NCT01970579 | Completed | Phase 3 | Clinical Trial on Peripheral Arteries Treated With SeQuent® Please P Paclitaxel Coated Balloon Catheter | October 2013 | December 2019 |
NCT02063672 | Completed | N/A | Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis | March 2014 | March 2019 |
NCT02621489 | Completed | Phase 4 | Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects | December 2015 | October 2022 |
NCT02649946 | Completed | N/A | Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft | June 2016 | February 2021 |
NCT02790606 | Completed | N/A | Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA) | July 2016 | March 16, 2019 |
NCT03141580 | Completed | N/A | Long-term Follow-up NIRS-IVUS Imaging of Pre-existing Carotid Stents | July 15, 2017 | November 1, 2019 |
NCT03332264 | Completed | N/A | Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions | March 30, 2017 | December 12, 2023 |
NCT00798954 | Completed | Phase 4 | Treatment of Bifurcation Lesions by SINGLE STENT and KISSing Balloon Trial | June 2007 | March 2010 |
NCT00987324 | Completed | Phase 4 | Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis | July 2009 | October 2013 |
NCT01016509 | Completed | N/A | Tight Glycemic Control During Angioplasty Revascularization Reduces Coronary Stent Restenosis | December 2009 | December 2010 |
NCT01065532 | Completed | N/A | SEDUCE OCT Study in Coronary Artery rEstenosis:an Optical Coherence Tomography (OCT) Study | May 2009 | December 2016 |
NCT01257438 | Completed | N/A | FLUENCY® PLUS Endovascular Stent Graft for In-stent Restenosis | December 2010 | January 2016 |
NCT01267838 | Completed | Phase 4 | Culotte Technique Versus TAP Stunting for the Treatment of de Novo Coronary Bifurcation Lesion With Drug-eluting Stents | February 2010 | April 2016 |
NCT05451368 | Recruiting | Neointimal Features in Patients With Restenosis of Calcified Lesions | March 17, 2022 | March 31, 2023 | |
NCT00780156 | Terminated | The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontinuation of Clopidogrel | November 2008 | February 2013 | |
NCT00712257 | Terminated | N/A | Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis | November 2007 | August 2009 |
NCT04514406 | Terminated | APERTO CVS PMCF Study | January 25, 2021 | December 1, 2023 | |
NCT03613337 | Unknown status | Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention | May 1, 2018 | August 31, 2020 | |
NCT03149913 | Unknown status | N/A | Local Paclitaxel or Balloon Angioplasty Below the Knee | December 15, 2016 | July 2020 |
NCT00774917 | Unknown status | Phase 2/Phase 3 | Numen Stent Assessment Using OCT Technique in a Single Center Study | October 2008 | March 2010 |
NCT01476020 | Unknown status | Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel | November 2011 | July 2015 | |
NCT01599078 | Unknown status | N/A | Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention | January 2012 | January 2014 |
NCT01298947 | Unknown status | N/A | Photoablative Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis in Instent Femoro-popliteal Obstructions | April 2011 | April 2013 |
NCT00696956 | Unknown status | Phase 2/Phase 3 | Drug Coated Balloons for Prevention of Restenosis | April 2008 | April 2011 |
NCT03858764 | Withdrawn | Local Paclitaxel Delivery to Prevent Restenosis in Peripheral Arterial Disease | August 2013 | August 2013 | |
NCT03146221 | Withdrawn | N/A | Search for Restenosis Markers in Lower Limb Arteritis | June 20, 2017 | June 20, 2020 |